A thrombocytosis occurring in Philadelphia positive CML in molecular response to imatinib can reveal an underlying JAK2 V617F myeloproliferative neoplasm
Titel:
A thrombocytosis occurring in Philadelphia positive CML in molecular response to imatinib can reveal an underlying JAK2 V617F myeloproliferative neoplasm
Auteur:
Véronèse, L. Tchirkov, A. Richard-Pebrel, C. Ledoux-Pilon, A. Fleury, J. Chaleteix, C. Goumy, C. Gouas, L. Berger, M.G. Vago, P. Bay, J.O. Tournilhac, O.